Comparison of Laser Photocoagulation Using 810 nm with 20 ms and 100 ms Duration on the Progression of Neovascularization in Proliferative Diabetic Retinopathy
Article Sidebar
Abstract
Background: The aim of this study was to compare the effectiveness of laser photocoagulation 810- nm with 20 ms and 100 ms duration to prevent the progression of proliferative diabetic retinopathy. Method: This study was prospective double blind randomized clinical trial. Twenty-eight participants who met the inclusion criteria divided into two groups to undergo laser photocoagulation by using 810 nm lasers. One group received 100 ms duration and the other received 20 ms duration. Grade 3 burns with a 200 μm spot sized were placed with both parameters. The progression of PDR was evaluated in two months follow up by using seven fields’ fundus photographs. Fluence, power and visual acuity were compared in this study.
Result: Twenty five subjects completed the two months follow up. The proportion of non-progressive PDR in 100 ms group was 75.0% and in 20 ms was 76.9% (p=1.000). The power in 20 ms group increased twice than 100 ms group (1000 vs. 500 mW; p=0.000). The median fluence in 20 ms group was less than 100 ms group (6.36 vs. 15.91 J/cm2; p=0.000). Improvement of visual acuity in 20 ms and 100 ms was comparable (23.1% vs. 33,3%; p=1.000).
Conclusion: The 20 ms duration showed similar result in preventing the progression of PDR compared to 100 ms duration.
Keywords: Proliferative diabetic retinopathy, laser photocoagulation, diode 810 nm
Full text article
References
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27:1047-53.
Sya’baniyah UN, Andayani G, Djatikusumo A. Prevalensi dan faktor risiko retinopati diabetik pada pasien diabetes mellitus berdasarkan skrining fotografi fundus di RS Cipto Mangunkusumo November 2010-Oktober 2011. Jakarta: Departemen Ilmu Kesehatan Mata. Fakultas Kedokteran Universitas Indonesia, 2012.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):766-85.
Regillo C, Holekamp N, Johnson MW, Kaiser PK, Schubert HD, Spaide R, et al. Retina and Vitreous. In: Basic and Clinical Science Course. San Francisco: American Academy of Ophthalmology, 2011:337-47.
Folk JC, Pulido JS. Laser photocoagulation of the retina and choroid. San Francisco: American Academy of Ophthalmology, 1997.
Han HJ, Oum BS. Diode laser panretinal photocoagulation in diabetic retinopathy. J Korean Ophthalmol Soc. 1995;36(11):1972 -79.
Bandello F, Brancato R, Trabucchi G, Lattanzio R, Malegori A. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time. Graefes Arch Clin Exp Ophthalmol. 1993;231(9):491-4.
Talu SD. Researches concerning the use of the diode laser (810 nm) in the treatment of the diabetic retinopathy. 1st International Conference on Advancements of Medicine and Health Care through Technology. Cluj-Napoca, Romania. 2007.
Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol. 1999;14(4):200-9.
Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye (Lond). 2011;25(11):1447-56.
Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (Lond.) 2008;22(1):96-9.
Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. RETINA. 2010;30(3):452-8.
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Statis.t 2005;4:287-91.
Salman AG. Pascal laser versus conventional laser for treatment of diabetic retinopathy. Saudi Journal of Ophthalmology. 2011;25(2):175-79.
Muraly P, Limbad P, Srinivasan K, Ramasamy K. Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparitive study. RETINA. 2011;31(7):1359-65.
Gopalakrishnan P. Influence of laser parameters on selective retinal photocoagulation for macular diseases. University of Cincinnati, 2005.
Schlott K, Langejürgen J, Bever M, Koinzer S, Birngruber R, Brinkmann R. Time resolved detection of tissue denaturation during retinal photocoagulation. In: Sroka R, Lilge LD, editors. Therapeutic Laser Applications and Laser-Tissue Interactions IV: Proceedings of the SPIE, 2009:73730E-30E-8.
Muqit MM, Marcellino GR, Gray JC, McLauchlan R, Henson DB, Young LB, et al. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2. Br J Ophthalmol. 2010;94(11):1493-8.
Alvarez-Verduzco O, Garcia-Aguirre G, Lopez-Ramos Mde L, Vera-Rodriguez S, Guerrero-Naranjo JL, Morales-Canton V. Reduction of fluence to decrease pain during panretinal photocoagulation in diabetic patients. Ophthalmic Surg Lasers Imaging. 2010;41(4):432-6.
Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmolog.y 1981;88(7):583-600.